Maximus

MMS

Market cap $4.78B

TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading employer and provider of government services, today announced it has been awarded a new $31 million contract by the Massachusetts Health Connector, an independent public authority. Under the four-year base contract, Maximus will provide enrollment and premium billing services. The Company will also launch a redesigned digital member portal to enhance the customer experience of more than 370,000 marketplace members. With this new contr.

HBM, GCT, WFRD, MMS and JXN have been added to the Zacks Rank #1 (Strong Buy) List on October 14, 2025.

TYSONS, Va.--(BUSINESS WIRE)--Maximus schedules its FY25 fourth quarter earnings call for Thursday, November 20, and will issue a release with its financial results that morning.

Investors target stocks that have been on a bullish run. Stocks like MMS, MD, SBH and STT are seeing price strength, and the momentum is likely to continue.

TYSONS, Va.--(BUSINESS WIRE)--Maximus announces a quarterly cash dividend of $0.30 per share.

TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE: MMS), a leading employer and provider of government services, today announced it was selected by Pennsylvania's Department of Human Services (DHS) to continue administering the Pennsylvania Enrollment Assistance Program under a five-year, $62 million contract. In partnership with DHS, Maximus has provided information about healthcare options, health plans, and providers to Pennsylvanians since 2009. Maximus currently assists eligible Pennsylvanians w.

Maximus has proven its business model resilient, with stable top- and bottom-line growth, margin expansion above historical averages, and strong EPS momentum supported by share buybacks. Federal Services is the growth engine, now 57% of revenue, where higher clinical volumes, scalability, and automation are driving margins above 18%, well ahead of other segments. U.S. Services faces YoY declines after pandemic unwinding, but longer-term growth opportunities remain through OBBBA-driven Medicaid checks, SNAP accuracy programs, and potential UI outsourcing.

Arista, Voya, Universal Health, Methanex and Maximus show strong 2025 sales growth potential despite near-term challenges.

MMS shines with a 17.5% YTD stock surge, earnings growth prospects, CMMC Level 2 certification and steady dividends.

TYSONS, Va.--(BUSINESS WIRE)--Maximus (NYSE:MMS), a leading employer and provider of government services, announced today that its Board of Directors has authorized an expansion to the purchase program for Maximus common stock to up to an aggregate of $400 million. This includes approximately $32.7 million of remaining availability under the existing stock purchase program. Maximus intends to purchase shares opportunistically at prevailing market prices in the open market, via 10b5-1 plans, or.